Economic burden of pertussis in children: A single-center analysis in Hangzhou, China
The "reemergence of pertussis" has elicited international concerns, occurring paradoxically amidst the expansion of immunization programs. This study was aimed to evaluate quantitatively the economic burden and identify the determinants that influence the cost associated with treating pert...
Saved in:
| Published in | Human vaccines & immunotherapeutics Vol. 20; no. 1; p. 2343199 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Taylor & Francis
31.12.2024
Taylor & Francis Group |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The "reemergence of pertussis" has elicited international concerns, occurring paradoxically amidst the expansion of immunization programs. This study was aimed to evaluate quantitatively the economic burden and identify the determinants that influence the cost associated with treating pertussis in Chinese children. We evaluated the economic burden by Chinese children diagnosed with pertussis at the Children's Hospital, Zhejiang University School of Medicine in 2022. Direct medical expenses and the utilization of medical resources attributed to pertussis were calculated. A generalized linear regression model was applied to analyze the determinants that were associated with the direct medical expenses among patients. Among the 1110 pertussis patients included in the study, 1060 were outpatients and 50 were inpatients. The average direct medical cost was ¥1878.70(i.e. $279.33). Living in urban areas (OR:1.27, p = .04), complications (OR:1.40, p < .001), hospitalization (OR:10.04, p < .001), and ≥ 3 medical visits (OR:3.71, p < .001) were associated with increased direct medical expenses. Having received four doses of the pertussis vaccine was associated with reduced direct medical expenses (OR:0.81, p = .04). This study underscores a substantial economic burden of pertussis in Hangzhou, with pronounced implications for patients residing in urban areas, experiencing complications, requiring hospitalization, having multiple medical consultations, or lacking comprehensive pertussis vaccination. |
|---|---|
| AbstractList | The "reemergence of pertussis" has elicited international concerns, occurring paradoxically amidst the expansion of immunization programs. This study was aimed to evaluate quantitatively the economic burden and identify the determinants that influence the cost associated with treating pertussis in Chinese children. We evaluated the economic burden by Chinese children diagnosed with pertussis at the Children's Hospital, Zhejiang University School of Medicine in 2022. Direct medical expenses and the utilization of medical resources attributed to pertussis were calculated. A generalized linear regression model was applied to analyze the determinants that were associated with the direct medical expenses among patients. Among the 1110 pertussis patients included in the study, 1060 were outpatients and 50 were inpatients. The average direct medical cost was ¥1878.70(i.e. $279.33). Living in urban areas (OR:1.27,
= .04), complications (OR:1.40,
< .001), hospitalization (OR:10.04,
< .001), and ≥ 3 medical visits (OR:3.71,
< .001) were associated with increased direct medical expenses. Having received four doses of the pertussis vaccine was associated with reduced direct medical expenses (OR:0.81,
= .04). This study underscores a substantial economic burden of pertussis in Hangzhou, with pronounced implications for patients residing in urban areas, experiencing complications, requiring hospitalization, having multiple medical consultations, or lacking comprehensive pertussis vaccination. The “reemergence of pertussis” has elicited international concerns, occurring paradoxically amidst the expansion of immunization programs. This study was aimed to evaluate quantitatively the economic burden and identify the determinants that influence the cost associated with treating pertussis in Chinese children. We evaluated the economic burden by Chinese children diagnosed with pertussis at the Children’s Hospital, Zhejiang University School of Medicine in 2022. Direct medical expenses and the utilization of medical resources attributed to pertussis were calculated. A generalized linear regression model was applied to analyze the determinants that were associated with the direct medical expenses among patients. Among the 1110 pertussis patients included in the study, 1060 were outpatients and 50 were inpatients. The average direct medical cost was ¥1878.70(i.e. $279.33). Living in urban areas (OR:1.27, p = .04), complications (OR:1.40, p < .001), hospitalization (OR:10.04, p < .001), and ≥ 3 medical visits (OR:3.71, p < .001) were associated with increased direct medical expenses. Having received four doses of the pertussis vaccine was associated with reduced direct medical expenses (OR:0.81, p = .04). This study underscores a substantial economic burden of pertussis in Hangzhou, with pronounced implications for patients residing in urban areas, experiencing complications, requiring hospitalization, having multiple medical consultations, or lacking comprehensive pertussis vaccination. The “reemergence of pertussis” has elicited international concerns, occurring paradoxically amidst the expansion of immunization programs. This study was aimed to evaluate quantitatively the economic burden and identify the determinants that influence the cost associated with treating pertussis in Chinese children. We evaluated the economic burden by Chinese children diagnosed with pertussis at the Children’s Hospital, Zhejiang University School of Medicine in 2022. Direct medical expenses and the utilization of medical resources attributed to pertussis were calculated. A generalized linear regression model was applied to analyze the determinants that were associated with the direct medical expenses among patients. Among the 1110 pertussis patients included in the study, 1060 were outpatients and 50 were inpatients. The average direct medical cost was ¥1878.70(i.e. $279.33). Living in urban areas (OR:1.27, p = .04), complications (OR:1.40, p < .001), hospitalization (OR:10.04, p < .001), and ≥ 3 medical visits (OR:3.71, p < .001) were associated with increased direct medical expenses. Having received four doses of the pertussis vaccine was associated with reduced direct medical expenses (OR:0.81, p = .04). This study underscores a substantial economic burden of pertussis in Hangzhou, with pronounced implications for patients residing in urban areas, experiencing complications, requiring hospitalization, having multiple medical consultations, or lacking comprehensive pertussis vaccination. The "reemergence of pertussis" has elicited international concerns, occurring paradoxically amidst the expansion of immunization programs. This study was aimed to evaluate quantitatively the economic burden and identify the determinants that influence the cost associated with treating pertussis in Chinese children. We evaluated the economic burden by Chinese children diagnosed with pertussis at the Children's Hospital, Zhejiang University School of Medicine in 2022. Direct medical expenses and the utilization of medical resources attributed to pertussis were calculated. A generalized linear regression model was applied to analyze the determinants that were associated with the direct medical expenses among patients. Among the 1110 pertussis patients included in the study, 1060 were outpatients and 50 were inpatients. The average direct medical cost was ¥1878.70(i.e. $279.33). Living in urban areas (OR:1.27, p = .04), complications (OR:1.40, p < .001), hospitalization (OR:10.04, p < .001), and ≥ 3 medical visits (OR:3.71, p < .001) were associated with increased direct medical expenses. Having received four doses of the pertussis vaccine was associated with reduced direct medical expenses (OR:0.81, p = .04). This study underscores a substantial economic burden of pertussis in Hangzhou, with pronounced implications for patients residing in urban areas, experiencing complications, requiring hospitalization, having multiple medical consultations, or lacking comprehensive pertussis vaccination.The "reemergence of pertussis" has elicited international concerns, occurring paradoxically amidst the expansion of immunization programs. This study was aimed to evaluate quantitatively the economic burden and identify the determinants that influence the cost associated with treating pertussis in Chinese children. We evaluated the economic burden by Chinese children diagnosed with pertussis at the Children's Hospital, Zhejiang University School of Medicine in 2022. Direct medical expenses and the utilization of medical resources attributed to pertussis were calculated. A generalized linear regression model was applied to analyze the determinants that were associated with the direct medical expenses among patients. Among the 1110 pertussis patients included in the study, 1060 were outpatients and 50 were inpatients. The average direct medical cost was ¥1878.70(i.e. $279.33). Living in urban areas (OR:1.27, p = .04), complications (OR:1.40, p < .001), hospitalization (OR:10.04, p < .001), and ≥ 3 medical visits (OR:3.71, p < .001) were associated with increased direct medical expenses. Having received four doses of the pertussis vaccine was associated with reduced direct medical expenses (OR:0.81, p = .04). This study underscores a substantial economic burden of pertussis in Hangzhou, with pronounced implications for patients residing in urban areas, experiencing complications, requiring hospitalization, having multiple medical consultations, or lacking comprehensive pertussis vaccination. |
| Author | Liu, Yan Yang, Yingying Zhang, Xiaoping Xie, Qixin Xu, Yuyang Gu, Lintao Lu, Zhaojun Hua, Chunzhen Zhang, Xuechao Zhou, Jinsi |
| Author_xml | – sequence: 1 givenname: Yan surname: Liu fullname: Liu, Yan organization: Hangzhou Center for Disease Control and Prevention – sequence: 2 givenname: Yingying surname: Yang fullname: Yang, Yingying organization: Hangzhou Center for Disease Control and Prevention – sequence: 3 givenname: Jinsi surname: Zhou fullname: Zhou, Jinsi organization: The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health – sequence: 4 givenname: Xuechao surname: Zhang fullname: Zhang, Xuechao organization: Hangzhou Center for Disease Control and Prevention – sequence: 5 givenname: Lintao surname: Gu fullname: Gu, Lintao organization: Hangzhou Center for Disease Control and Prevention – sequence: 6 givenname: Yuyang surname: Xu fullname: Xu, Yuyang organization: Hangzhou Center for Disease Control and Prevention – sequence: 7 givenname: Zhaojun surname: Lu fullname: Lu, Zhaojun organization: Hangzhou Center for Disease Control and Prevention – sequence: 8 givenname: Qixin surname: Xie fullname: Xie, Qixin organization: Hangzhou Center for Disease Control and Prevention – sequence: 9 givenname: Xiaoping surname: Zhang fullname: Zhang, Xiaoping organization: Hangzhou Center for Disease Control and Prevention – sequence: 10 givenname: Chunzhen orcidid: 0000-0003-2829-5878 surname: Hua fullname: Hua, Chunzhen email: Chuachunzhen@zju.edu.cn organization: The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38647026$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFUstuFDEQtFAQCSGfAJojB2bxYzwPOIRoFUikSFyIxM1qP2bXkcde7BnQ5uvjYTcrwgF8cbu7qtpt10t05IM3CL0meEFwi99TUlecE76gmFYLyipGuu4ZOpnzJefV96NDTPgxOkvpDufVZHRdv0DHrK2rfKhP0O2lCj4MVhVyitr4IvTFxsRxSsmmwvpCra3T0fgPxUWRrF85UyrjRxML8OC2e9QV-NX9OkzviuXaeniFnvfgkjnb76fo9vPlt-VVefP1y_Xy4qZUnPGxlLKvTMc11V1PNAUwnDGda6SqNdGSMk5bxWpoKDWS9bIFwDKHplGMyJ6douudrg5wJzbRDhC3IoAVvxMhrgTE0SpnRNt0WGtDmraRFWUNYNL1-S0b1mEiG561zndam0kORs9DRnBPRJ9WvF2LVfgpCMGsoS3LCm_3CjH8mEwaxWCTMs6BN2FKguGKE8JajDP0zZ_NDl0ePyYD-A6gYkgpmv4AIVjMHhCPHhCzB8TeA5n38S-esiOMNsx3tu6_7E87tvV9iAP8CtFpMcLWhdhH8MrmKf4t8QAEL8md |
| CitedBy_id | crossref_primary_10_1186_s12889_025_21329_y |
| Cites_doi | 10.1016/j.vaccine.2023.09.008 10.1007/s41669-018-0081-4 10.1017/S0950268801005593 10.1016/j.jped.2015.03.006 10.1097/INF.0000000000001761 10.1080/23744235.2018.1457796 10.1017/S0950268811002044 10.1007/s004310050837 10.1099/jmm.0.001442 10.1055/s-2006-957208 10.1016/j.epidem.2011.10.001 10.1016/j.ijid.2019.05.014 10.1111/apa.15259 10.1007/s150100050056 10.1016/j.vaccine.2019.09.100 10.1016/j.pop.2018.05.003 10.1097/INF.0000000000001440 10.1016/S1473-3099(03)00669-8 10.4161/hv.26335 10.1016/j.vaccine.2010.11.059 10.1016/S0140-6736(06)68848-X 10.1007/s00430-017-0524-z 10.1093/cid/ciy757 10.1017/S0950268823001577 10.1016/j.jval.2022.10.011 10.1017/S0950268820000102 10.1016/j.vaccine.2015.10.136 10.1016/j.vaccine.2023.08.046 10.1016/S1473-3099(17)30230-X 10.1016/S1473-3099(17)30390-0 10.1098/rspb.2015.2309 |
| ContentType | Journal Article |
| Copyright | 2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) |
| Copyright_xml | – notice: 2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 – notice: 2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) |
| DBID | 0YH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
| DOI | 10.1080/21645515.2024.2343199 |
| DatabaseName | Taylor & Francis Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journal Collection |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 0YH name: Taylor & Francis Open Access url: https://www.tandfonline.com sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| DocumentTitleAlternate | Y. LIU ET AL |
| EISSN | 2164-554X |
| ExternalDocumentID | oai_doaj_org_article_8790dde1787b4237a019f08073901b75 PMC11037283 38647026 10_1080_21645515_2024_2343199 2343199 |
| Genre | Research Article Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GrantInformation_xml | – fundername: the Science and Technology Program of Zhejiang Province grantid: 2021KY267 – fundername: Hangzhou health science and technology plan grantid: A20230202 – fundername: Natural Science Foundation of Zhejiang Province grantid: LGF18H010001 |
| GroupedDBID | --- 00X 0YH 30N 4.4 53G AALUX ABEIZ ABUPF ACGFS ADBBV ADCVX AECIN AENEX AGYJP AIJEM ALMA_UNASSIGNED_HOLDINGS ALQZU AOIJS ARJSQ BABNJ BAWUL BLEHA BOHLJ CCCUG DGEBU EBS EMOBN GROUPED_DOAJ KYCEM LJTGL M4Z O9- RIG RPM SV3 TDBHL TFL TFW TTHFI AAYXX CITATION H13 CGR CUY CVF ECM EIF NPM 7X8 5PM DIK HYE |
| ID | FETCH-LOGICAL-c535t-bbf4e95d2d9f1d2aae533dc53146d1db23528c36a722eb3fb8aa0b2ebe7c31bf3 |
| IEDL.DBID | 0YH |
| ISSN | 2164-5515 2164-554X |
| IngestDate | Wed Aug 27 01:26:39 EDT 2025 Thu Aug 21 18:34:47 EDT 2025 Fri Jul 11 09:26:03 EDT 2025 Thu Apr 03 07:02:12 EDT 2025 Sun Jul 06 05:05:26 EDT 2025 Thu Apr 24 22:54:09 EDT 2025 Tue Apr 15 04:10:27 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | direct medical costs pertussis vaccination pertussis factors |
| Language | English |
| License | open-access: http://creativecommons.org/licenses/by-nc/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c535t-bbf4e95d2d9f1d2aae533dc53146d1db23528c36a722eb3fb8aa0b2ebe7c31bf3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed to the work equally and should be regarded as co-first authors. |
| ORCID | 0000-0003-2829-5878 |
| OpenAccessLink | https://www.tandfonline.com/doi/abs/10.1080/21645515.2024.2343199 |
| PMID | 38647026 |
| PQID | 3045113800 |
| PQPubID | 23479 |
| ParticipantIDs | informaworld_taylorfrancis_310_1080_21645515_2024_2343199 proquest_miscellaneous_3045113800 doaj_primary_oai_doaj_org_article_8790dde1787b4237a019f08073901b75 crossref_primary_10_1080_21645515_2024_2343199 pubmed_primary_38647026 crossref_citationtrail_10_1080_21645515_2024_2343199 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11037283 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-12-31 |
| PublicationDateYYYYMMDD | 2024-12-31 |
| PublicationDate_xml | – month: 12 year: 2024 text: 2024-12-31 day: 31 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Human vaccines & immunotherapeutics |
| PublicationTitleAlternate | Hum Vaccin Immunother |
| PublicationYear | 2024 |
| Publisher | Taylor & Francis Taylor & Francis Group |
| Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Group |
| References | e_1_3_6_30_1 e_1_3_6_31_1 e_1_3_6_32_1 e_1_3_6_33_1 e_1_3_6_11_1 e_1_3_6_10_1 e_1_3_6_15_1 e_1_3_6_14_1 e_1_3_6_13_1 e_1_3_6_12_1 e_1_3_6_19_1 e_1_3_6_18_1 e_1_3_6_17_1 e_1_3_6_16_1 e_1_3_6_20_1 e_1_3_6_21_1 e_1_3_6_22_1 e_1_3_6_2_1 e_1_3_6_6_1 e_1_3_6_5_1 e_1_3_6_4_1 e_1_3_6_3_1 e_1_3_6_9_1 e_1_3_6_8_1 e_1_3_6_7_1 e_1_3_6_27_1 e_1_3_6_28_1 e_1_3_6_29_1 e_1_3_6_23_1 e_1_3_6_24_1 e_1_3_6_25_1 e_1_3_6_26_1 |
| References_xml | – ident: e_1_3_6_24_1 doi: 10.1016/j.vaccine.2023.09.008 – ident: e_1_3_6_31_1 doi: 10.1007/s41669-018-0081-4 – ident: e_1_3_6_25_1 doi: 10.1017/S0950268801005593 – ident: e_1_3_6_28_1 doi: 10.1016/j.jped.2015.03.006 – ident: e_1_3_6_8_1 doi: 10.1097/INF.0000000000001761 – ident: e_1_3_6_30_1 doi: 10.1080/23744235.2018.1457796 – ident: e_1_3_6_22_1 doi: 10.1017/S0950268811002044 – ident: e_1_3_6_27_1 doi: 10.1007/s004310050837 – ident: e_1_3_6_4_1 doi: 10.1099/jmm.0.001442 – ident: e_1_3_6_11_1 doi: 10.1055/s-2006-957208 – ident: e_1_3_6_18_1 doi: 10.1016/j.epidem.2011.10.001 – ident: e_1_3_6_20_1 doi: 10.1016/j.ijid.2019.05.014 – ident: e_1_3_6_32_1 doi: 10.1111/apa.15259 – ident: e_1_3_6_10_1 doi: 10.1007/s150100050056 – ident: e_1_3_6_26_1 doi: 10.1016/j.vaccine.2019.09.100 – ident: e_1_3_6_9_1 – ident: e_1_3_6_7_1 doi: 10.1016/j.pop.2018.05.003 – ident: e_1_3_6_29_1 doi: 10.1097/INF.0000000000001440 – ident: e_1_3_6_5_1 doi: 10.1016/S1473-3099(03)00669-8 – ident: e_1_3_6_12_1 doi: 10.4161/hv.26335 – ident: e_1_3_6_16_1 doi: 10.1016/j.vaccine.2010.11.059 – ident: e_1_3_6_2_1 doi: 10.1016/S0140-6736(06)68848-X – ident: e_1_3_6_13_1 doi: 10.1007/s00430-017-0524-z – ident: e_1_3_6_21_1 doi: 10.1093/cid/ciy757 – ident: e_1_3_6_33_1 doi: 10.1017/S0950268823001577 – ident: e_1_3_6_15_1 doi: 10.1016/j.jval.2022.10.011 – ident: e_1_3_6_6_1 doi: 10.1017/S0950268820000102 – ident: e_1_3_6_3_1 doi: 10.1016/j.vaccine.2015.10.136 – ident: e_1_3_6_17_1 doi: 10.1016/j.vaccine.2023.08.046 – ident: e_1_3_6_23_1 doi: 10.1016/S1473-3099(17)30230-X – ident: e_1_3_6_14_1 doi: 10.1016/S1473-3099(17)30390-0 – ident: e_1_3_6_19_1 doi: 10.1098/rspb.2015.2309 |
| SSID | ssj0000702466 |
| Score | 2.3565712 |
| Snippet | The "reemergence of pertussis" has elicited international concerns, occurring paradoxically amidst the expansion of immunization programs. This study was aimed... The “reemergence of pertussis” has elicited international concerns, occurring paradoxically amidst the expansion of immunization programs. This study was aimed... |
| SourceID | doaj pubmedcentral proquest pubmed crossref informaworld |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2343199 |
| SubjectTerms | Adolescent Child Child, Preschool China - epidemiology Cost of Illness direct medical costs factors Female Health Care Costs - statistics & numerical data Hospitalization - economics Hospitalization - statistics & numerical data Humans Infant Licensed Vaccines Male pertussis pertussis vaccination Pertussis Vaccine - administration & dosage Pertussis Vaccine - economics Vaccination - economics Whooping Cough - economics Whooping Cough - epidemiology Whooping Cough - prevention & control |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journal Collection dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA4iCF7Et_VFBI9Wt3lsW2-ruCyCnlzwFpImUUG6y9o96K93Jm3XXRH24q2kSdtkJplvmsw3hJxLI11hTRpbqX0soFqscybjQtrUcMNsEVKyPDx2B0Nx_yyf51J94Zmwmh64HrirLM07MAUTUCyDRzg0YBIPMCdFZ92kgb0UbN6cMxXW4BRsT9ioZOAPxAALZBu-k3WusAyLwD1k4pJxMKKB-_XHMAX-_l_spX9h0N9HKedsU3-TbDSgkvbqzmyRFVduk7U6zeTnDhm20cfUhKAFOvJ07CbVFObDB30raRvRfU17FP8dvLsY3-QmVDecJVhroMuXr9fR9IKGpNu7ZNi_e7odxE06BRh4LqvYGC9cLi2zuU8s09oB1ANZcFgsbWINQ6KXgnd1yhi42N5kWncMXLq04InxfI-slqPSHRBqeQFPEpghAvzrQmsjfJ4YMG1cAMThERHtWKqi4RrHlBfvKmkoSVsRKBSBakQQkctZs3FNtrGswQ0KalYZubJDAWiQajRILdOgiOTzYlZV-FXi67wmii_5gLNWJxTMS9xs0aUbTaEdEvckHPB4RPZrHZl9Js-6AhS0G5FsQXsW-rF4p3x7DdzfCcZ1AiQ8_I-eH5F17EzNW3lMVqvJ1J0AxqrMaZhO33vDG1I priority: 102 providerName: Directory of Open Access Journals |
| Title | Economic burden of pertussis in children: A single-center analysis in Hangzhou, China |
| URI | https://www.tandfonline.com/doi/abs/10.1080/21645515.2024.2343199 https://www.ncbi.nlm.nih.gov/pubmed/38647026 https://www.proquest.com/docview/3045113800 https://pubmed.ncbi.nlm.nih.gov/PMC11037283 https://doaj.org/article/8790dde1787b4237a019f08073901b75 |
| Volume | 20 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9swDCa2DgN2GbZ1D-9RaECPcxfrEce7tcWKYEB7WoD2JIiW1BYo7CJxDtuvHynbQVNs6GG3OBFlxSRFiiY_AuwbNKH2WObeuJhrGpa7Spq8Nr5EhdLXqSXL6dl0vtA_zs2YTbga0ir5DB17oIi0V7NyO1yNGXFfJbn4ZOgNne6kPpCKbGBVPYYnZIkn3MRgcjHfhFlIomX_xpKpciYb63j-NdOWhUpA_vdgTP_mjN7PqbxjpE5ewPPBuxSHvTi8hEeheQVP-36Tv3ZhMZYhC0zVC6KN4jYsuzUpxkpcN2Is7f4mDgUHEW5CzncKS-EG8BIeNXfN5e-rdv1FpO7br2Fx8v3n8Twf-ioQB5TpcsSoQ2W89FUsvHQukM9HTFG0a_rCo2TEl1pNXSklnbUjzpybIH0MZa0KjOoN7DRtE96B8KqmmTS3iqCDdu0c6lgVSDZOafJ1VAZ6fJa2HkDHuffFjS0GbNKRBZZZYAcWZHCwIbvtUTceIjhiRm0GM2h2-qJdXtpBB-2srCa0mxe0RyFnAzlybyNNWXLcB0uTQXWXzbZLMZPYNzix6oEFfB5lwpKC8lsX14R2TXSM4FMocswzeNvLyGaZajbVJKDTDGZb0rP1P7Z_aa6vEgh4wQWe5Bu-_49Ff4BnfNnjVn6EnW65Dp_Ix-pwL2nRXopQ_AHEIRrU |
| linkProvider | Taylor & Francis |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9swDCa2DsN2Wfeuu5cG7DinsWTZ8W7tsCLb2pwaoDdBz7ZYYRepfVh_fUk_giTY0ENvhi0KepAiRZMfAb5II711Jo-d1CFOsVmsCy5jK11uhOHOtiVZjmfZdJ7-OpWnK7kwFFZJd-jQAUW0ZzUJNzmjh5C4PY42Pmp6idc7no64QCVYFA_hkSyynHhdjGdLPwuyNO9-WRJVTGRDIs__elpTUS2S_waO6b-s0c2gyhUtdbgNdphfF5zyZ9TUZmRvNqAf77cAz-FZb8Sy_Y7rXsADX76Ex11Zy7-vYD5kOzPTJkmwKrArv6gblL9rdlGyIYP8G9tn5Ku49DHNxy-Y7jFSqNVUl2c351XzlbVFvl_D_PDHyfdp3JdvwI0Wso6NCakvpOOuCInjWns0LXHvBR7OLnGGE7CMFZnOOccrfTATrccGH31uRWKCeANbZVX6HWBOWOwppYoUeJ-3Wps0FIlBVSpSNKlEBOmwY8r22OZUYuNSJT0E6rBiilZM9SsWwWhJdtWBe9xFcEDssGxM2Nzti2pxpnpRV5O8GKPSSPAoNBR0pNGKDthlTu4lk8sIilVmUnXrmgldHRUl7hjA54HzFJ4D9HNHl75qkI6AghKB9n8EbztOXA5TTLIUxSCLYLLGo2vzWP9SXpy3WOMJ5ZGiCbp7j0F_gifTk-MjdfRz9vsdPKVPHVTme9iqF43_gGZdbT62cnsLHN49Ww |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BEagXyrspLyNxJMvGjpMNtxZYLa8VB1biZvnZVlTJapsc6K_vTB6r7grUQ29R7LH8mPGM7ZlvAN5KI711Jo-d1CFOsVqsCy5jK11uhOHOtilZfsyz2SL9-lsO3oTnvVslnaFDBxTR7tUk3EsXBo-49xxNfFT0Ek93PB1xgTqwKG7DnYwCLSmKYzxfX7MgR_PuxZKoYiIb4nj-19KGhmqB_LdgTP9ljG77VF5RUtM9MMPwOt-UP6OmNiN7sYX8eKPxP4D7vQnLDjueewi3fPkI7nZJLf8-hsUQ68xMGyLBqsCWflU3KH3n7LRkQ_z4B3bI6KbizMc0HL9iukdIoVozXR5fnFTNO9am-H4Ci-nnXx9ncZ-8AZdZyDo2JqS-kI67IiSOa-3RsMSVF7g1u8QZTrAyVmQ65xwP9MFMtB4b_PS5FYkJ4inslFXp94E5YbGllPJR4ApbrU0aisSgIhUpGlQignRYMGV7ZHNKsHGmkh4AdZgxRTOm-hmLYLQmW3bQHtcRHBE3rCsTMnf7o1odq17Q1SQvxqgyEtwIDbkcabShAzaZ0-WSyWUExVVeUnV7MRO6LCpKXNOBNwPjKdwF6GlHl75qkI5gghKB1n8EzzpGXHdTTLIUpSCLYLLBohvj2CwpT09apPGEokjRAD24Qadfw72fn6bq-5f5t-ewSyUdTuYL2KlXjX-JNl1tXrVSewn3wzv_ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Economic+burden+of+pertussis+in+children%3A+A+single-center+analysis+in+Hangzhou%2C+China&rft.jtitle=Human+vaccines+%26+immunotherapeutics&rft.au=Liu%2C+Yan&rft.au=Yang%2C+Yingying&rft.au=Zhou%2C+Jinsi&rft.au=Zhang%2C+Xuechao&rft.date=2024-12-31&rft.issn=2164-5515&rft.eissn=2164-554X&rft.volume=20&rft.issue=1&rft_id=info:doi/10.1080%2F21645515.2024.2343199&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_21645515_2024_2343199 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2164-5515&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2164-5515&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2164-5515&client=summon |